China and its Regions Strengthen Tobacco Control Measures

Regulations by 2FIRSTS.ai
Dec.22.2023
China and its Regions Strengthen Tobacco Control Measures
China Smoke Control Association recently held a smoke control exchange event in Shanghai, aiming to promote a healthy China.

According to a report on December 21 by the Central People's Broadcasting Station website, the China Tobacco Control Association recently held a tobacco control exchange event in Shanghai, involving the mainland, Taiwan, Hong Kong, and Macau regions. During the event, tobacco control workers and academic experts from Shanghai, Hong Kong, and Macau shared their experiences and achievements in tobacco control, with the aim of collectively promoting the construction of a healthy China.

 

The implementation of the "Shanghai Initiative" in tobacco control aims to improve life expectancy. Since the implementation of smoking regulations in public places in Shanghai since 2010, the city's tobacco control efforts have been strengthening social governance, forming a "six-one" model of tobacco control promotion, supervision, and law enforcement. This model includes one system, one mechanism, one guideline, one graphic, one network, and a series of working methods, and has achieved remarkable results.

 

The adult smoking rate in Shanghai has shown a continuous downward trend for 12 consecutive years, with the smoking rate in 2022 reaching a record low of 19.4%. This represents a significant decline of 7.5 percentage points since the implementation of anti-smoking legislation in 2010, and is considerably lower than the national average smoking rate of 24.1%. Moreover, Shanghai has achieved the targets set under the "Healthy China 2030" initiative ahead of schedule. Furthermore, according to the results of the 2021 National Survey on Tobacco Use among Youth, the prevalence of cigarette and e-cigarette use among middle school students in Shanghai is the lowest among all 31 provinces in the country.

 

Over the past decade or so, Shanghai has consistently provided a replicable and scalable "Shanghai model" for tobacco control efforts nationwide and urban governance. The first mainland tobacco control law legislated by the National People's Congress in 2007 has served as a great guiding force and support for the overall process of tobacco control legislation in the country.

 

Hong Kong and Macau also shared their achievements in tobacco control during the event and discussed new strategies to tackle dual challenges. Currently, tobacco control efforts are facing challenges from both new tobacco products and traditional tobacco products. Experts at the conference stated that future tobacco control work will continue to focus on aspects such as smoke-free legislation, smoke-free environments, tobacco monitoring, warning about tobacco hazards, smoking cessation services, smoking-related diseases, youth tobacco control, tobacco taxes and prices, banning tobacco advertising, promotion and sponsorship, as well as e-cigarettes. These efforts aim to promote social governance in tobacco control and contribute to the construction of a healthy China.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.
State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.
State Tobacco Monopoly Administration director Zhang Jianmin met with Korean Tobacco Company president Fang Jingwan in Beijing on October 31.
Nov.03 by 2FIRSTS.ai
Product | NEXA FLEX Releases “Built in the USA” Version, Says All Flavors Are Tailored for Adult U.S. Users
Product | NEXA FLEX Releases “Built in the USA” Version, Says All Flavors Are Tailored for Adult U.S. Users
NEXA has introduced a disposable e-cigarette, NEXA FLEX, which is promoted as “Built in the USA,” highlighting domestic production and flavors developed for adult U.S. vaping consumers. The device retains features such as a transparent e-liquid chamber, Normal/Turbo dual modes, and up to 40,000 puffs, and is scheduled to launch in late November in Texas. Other brands, including SKE and FASTA, have also recently released products labeled as “Made in the USA” or “U.S.-assembled.”
Nov.20 by 2FIRSTS.ai
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.
Oct.13
St. Petersburg May Become Russia’s First Region to Ban Vape Sales
St. Petersburg May Become Russia’s First Region to Ban Vape Sales
St. Petersburg may become the first region in Russia to ban the sale of vapes. Senator Andrei Kutepov announced during a session of the Legislative Assembly that he is working to introduce restrictions on vape sales in the city, in line with President Vladimir Putin’s recent statement supporting a nationwide ban.
Nov.12 by 2FIRSTS.ai
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.
Nov.06
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai